Synopsis The global Surgical Mask market size is expected to reach US$ 69 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Surgical Mask in various end use industries. The expa.....
SynopsisLong-term care (LTC) is a variety of services which help meet both the medical and non-medical needs of people with a chronic illness or disability who cannot care for themselves for long periods. Long term care is focused on individualized and coordinated ser.....
SynopsisIn dentistry, a veneer is a layer of material placed over a tooth, veneers improve the aesthetics of a smile and/or protect the tooth's surface from damage. There are two main types of material used to fabricate a veneer: composite and dental porcelain. .....
SynopsisThe global Turmeric Formulas market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Turmeric Formulas in various end use industries. The expanding demands f.....
SynopsisNon-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation. The global Nonalcoholic Steatohepatitis (NASH) market size is.....
SynopsisAbatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a modified antibody. The global Orencia (Abatacept) Drug market size is expected to reach US$.....
SynopsisKidney fibrosis is characterized by excessive production and deposition of extracellular matrix (ECM) proteins mainly in the kidney interstitium and results in structural damage, impairment of renal function, and eventually end-stage renal disease (ESRD).
SynopsisThe global Positron Emission Tomography (PET) Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Positron Emission Tomography (PET) Systems in v.....
SynopsisGemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The global Gemtuzumab Ozogamicin market size is expected to reach US$ 179.5 million by 2029, growing .....
SynopsisRITUXAN is a type of antibody therapy that can be used alone or with chemotherapy. The global Rituxan market size is expected to reach US$ 469.8 million by 2029, growing at a CAGR of -10.5% from 2023 to 2029. The market is mainly driven by the significan.....
